Responses to: Combatting Lyme disease myths and the ‘chronic Lyme industry’ – Canadian Medical Association Journal

Insert HTML here
BY CHRIS ROBINSON [ – Chris Robinson is a health economist / epidemiologist, and former head of Evidence and Risk Assessment Division, Centre for Chronic Disease Prevention and Control, Public Health Agency of Canada. He is now retired and living in Cavendish ] January 9th, 2017 published by The Guardian There are no deer on P.E.I….
Interview with Prof. Ying Zhang at the NorVect Conference 2015 Published on Sep 29, 2015 Prof Ying Zhang from John Hopkins Bloomberg School of Public Health explains why Lyme disease is so difficult to treat. Having worked with Tuberculosis (TB) for many years, he sees the similarities and differences between these to bacteria. With…
https://doi.org/10.3928/01477447-20190627-01 Abstract Periprosthetic infections occur in approximately 0.8% to 1.9% of all total knee arthroplasties (TKAs). Even with these low rates, it is rare to find a zoonotic bacterium causing a periprosthetic infection. In this case report, the authors identify the second documented case of a total joint infection with Francisella tularensis in the world and the…
June 22nd, 2015 by Christopher Gooding SPRINGHILL – It’s enough to make anyone want to stay out of the woods. Well, almost anyone. Springhill and Pugwash Ground Search and Rescue members met July 17 to learn about the increasingly prevalent world of ticks. Many searchers had their first experiences with the little critters known for…
Nov 15th, Last Friday, 28 patients filed a federal antitrust lawsuit against the Infectious Diseases Society of America, eight health insurance companies, and seven medical doctors, Courthouse News reported yesterday, “because health insurers are denying coverage with bogus guidelines established by their paid consultants, who falsely say the disease can always be cured with a month of antibiotics.” Contrary…
Sarah explores the latest advances in Lyme disease treatment with Dr. Kim Lewis, a researcher, author, University Distinguished Professor and director of Antimicrobial Discovery Center at Northeastern University in Boston. He specializes in molecular science and is currently researching persister cells that lead to tolerance to antibiotics, uncultured bacteria of the environment and the microbiome…
LymeNB reacts to CMAJ news article: Combatting Lyme disease myths and the ‘chronic Lyme industry’ by Wendy Glauser, Toronto. September 17, 2019
LymeNB was horrified to read the CMAJ news article published on September 17 that spoke about how the patient-facing toolkit being developed by the Centre for Effective Practice (CEP) in partnership with the Association of Medical Microbiology and Infectious Disease (AMMI) in Canada would serve to combat, as the title suggested, Lyme disease myths and the ‘chronic Lyme industry’. How disrespectful for the patient community! … Read full text
———————————
Margaret Schaefer, Registered Nurse, Litchfield County Lyme Network
Picture a two year old child running through the beautiful fields and forests of Connecticut. Then picture two weeks down the line the child presents with a febrile illness in the middle of July. The parents are informed by the pediatrician that the child has a “summer flu”. The parents were not warned sufficiently … Read full text
———————————
[CanLyme Note: The science is very weak for the effectiveness of prophylaxis. Doctors Canada wide are also improperly administering this as a treatment, not prevention. CanLyme receives many complaints from individuals. There is much misinformation in the medical literature, most of which comes from private infectious disease organizations who do not follow ethical standards for what constitutes medical evidence. Infectious disease physicians are not scientists yet they put themselves forward as experts, so be very wary of the following…]
Eugene Y.H., Resident physician, Faculty of Medicine, The University of Ottawa, ON, Canada
I see that this CMAJ article is mainly advocating against over-treating unconfirmed Lyme’s disease. However, I would also like to bring up the counterargument, in which clinicians hesitate to start Lyme disease prophylaxis that lead to adverse consequences to patients, such as arthritis and cranial nerve palsies… Read full text.
Original article